Paperplane Therapeutics
PrivateLast Round
Seed
Nov 1, 2024
Total Funding Raised
$1.82M
Company Overview
Paperplane Therapeutics operates in Healthcare & Life Sciences and is based in Granby, Quebec. Its latest recorded funding round was a Seed round in November 2024.
Paperplane Therapeutics is a healthtech company that provides virtual reality therapies intended to manage patient pain and anxiety.
Sector
Healthcare & Life Sciences
Verticals
AR/VR Experiences, Medical Devices, Mental Health, Patient Engagement, AR/VR Hardware
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paperplane Therapeutics Comparables
Compare Paperplane Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HypnoVR | 86% | |
| Wide Awake VR | 83% | |
| Novobeing | 81% |
For institutional investors. Book with your work email.
Paperplane Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2024 | ||||
| Grant | Aug 23, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Paperplane Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| The MAYDAY Fund | Grant |
| Anges Quebec | Seed |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
| Glen Ventures | Seed |
| Cedars-Sinai Intellectual Property Company | Seed |
| Centre for Aging and Brain Health Innovation | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors increased 71% MoM.
- May 3, 2025
Grew 57% QoQ from 7 to 11 employees.
For institutional investors. Book with your work email.
Paperplane Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Paperplane Therapeutics's valuation, stock price, and market status.
Is Paperplane Therapeutics a public or private company?
Paperplane Therapeutics is a private company.
What is the current stock price of Paperplane Therapeutics?
Paperplane Therapeutics is a private company, so its shares have no public market price. Caplight tracks Paperplane Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Paperplane Therapeutics worth (valuation)?
Valuation information for Paperplane Therapeutics is not publicly available.
Can I buy Paperplane Therapeutics stock?
Paperplane Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Paperplane Therapeutics's last funding round?
Paperplane Therapeutics's most recent funding round was Seed on November 1, 2024.
Who are the main investors in Paperplane Therapeutics?
Key investors in Paperplane Therapeutics include Glen Ventures.
Will Paperplane Therapeutics IPO soon?
No public IPO plans have been announced for Paperplane Therapeutics.
How can I track Paperplane Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Paperplane Therapeutics's shares on secondary markets.